AIMCA
GHDX

Alberta Investment Management Corp (AIMCo)’s Genomic Health, Inc. GHDX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,300
Closed -$1.84M – 1070
2019
Q1 		$1.84M Buy
26,300
+12,000
+84% +$890K 0.02% 483
2018
Q4 		$921K Buy
+14,300
New +$1M 0.01% 573

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s GHDX Position: Q2 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 26,300 shares — an estimated $1.84M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $1.84M in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 26,300 Genomic Health, Inc. shares in Q2 2019, an estimated $1.84M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Genomic Health, Inc. position peaked at $1.84M in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2019, filed 14 Aug 2019.